|
|
Antwerp, 5 September, 8:00 AM CET
iSTAR Medical announces EUR 40.1 million financing round lead by
Gimv to support further development of an innovative glaucoma
treatment
iSTAR Medical SA, a Wavrebased private medical device company developing novel
ophthalmic implants for the treatment of glaucoma, today announces the completion of a EUR
40.1... See more |
|
| |
|
| |
|
|
Antwerp BE, 30 July 2019, 8:00 CET
AgroSavfe raises EUR 35 million, Gimv invests additional resources for
further development of biocontrols as a new standard for sustainable
crop protection
Gimv is increasing its commitment to AgroSavfe, an innovative food and agrobiotech company
developing environmentally friendly plant protection products. As... See more |
|
| |
|
| |
|
|
Munich/Stuttgart, 30. July 2019, 7:45 CET
Gimv sells stake in thinkstep AG, the Stuttgartbased specialist in
sustainability software
Gimv, together with all other shareholders, is selling its stake in Stuttgartbased software firm thinkstep
AG www.thinkstep.com to US software provider Sphera Solutions. Thanks to the longterm support of
all investors,... See more |
|
| |
|
| |
|
|
Antwerpen, 30 July 2019, 7:30 CET
Gimv exits Legallais, ironmongery distributor for building professionals
in France.
Gimv today announced its exit from French company Groupe Legallais, in which it has held a minority stake
since February 2016. Founded in 1889, Legallais is a leading independent distributor of ironmongery and
finishing work products for... See more |
|
| |
|
| |
|
|
Antwerp BE / Münich GER, 25 July 2019, 8:00 CET
Gimv and other shareholders sell biopharmaceutical company Breath
Therapeutics to Zambon after a fast development
Today, Gimv, Sofinnova and Gilde Healthcare announced the sale of biopharmaceutical company Breath
Therapeutics. Specialising in advanced and firstinclass inhalation therapies for severe respiratory
... See more |
|
| |
|
| |
|
|
Search :
